Lallemand Health Solution (LHS), with more than 80 years of expertise in probiotics, is committed to continuing R&D work on bacteria and yeasts. The R&D center of LHS is located at the National Research Council of Canada (CNRC). Lallemand has more than 330 publications, covering in vitro trials, in vivo models and clinical trials. Health segments covers gut health, natural immunity, mental health, women’s health, oral health, sports health, metabolic health, etc.
︎ Highly effective, resistant to gastric acid and bile, strong adhesion capacity on intestinal epithelial cells; ︎ Safety guarantee by whole genome sequencing and screening for antibiotic resistance;
︎ Registered in Institute Pasteur, meeting the requirements of Ministry of Health;
︎ Supported by Protective matrix and optimized manufacturing process & Patented microencapsulation technology.
